{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:57:14Z","timestamp":1758815834992,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Genetic familiar causes of oro-facial dyskinesia are usually restricted to Huntington\u2019s disease, whereas other causes are often missed or underestimated. Here, we report the case of late-onset oro-facial dyskinesia in an elderly patient with a genetic diagnosis of Spinocerebellar Ataxia type 2 (SCA2).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 75-year-old man complained of progressive balance difficulty since the age of 60\u2009years, associated with involuntary movements of the mouth and tongue over the last 3 months. No exposure to anti-dopaminergic agents, other neuroleptics, antidepressants, or other drugs was reported. Family history was positive for SCA2 (brother and the son of the brother). At rest, involuntary movements of the mouth and tongue were noted; they appeared partially suppressible and became more evident during stress and voluntary movements. Cognitive examination revealed frontal-executive dysfunction, memory impairment, and attention deficit. Brain magnetic resonance imaging (MRI) disclosed signs of posterior periventricular chronic cerebrovascular disease and a marked ponto-cerebellar atrophy, as confirmed by volumetric MRI analysis. A dopamine transporter imaging scan demonstrated a bilaterally reduced putamen and caudate nucleus uptake. Ataxin-2 (<jats:italic>ATXN2<\/jats:italic>) gene analysis revealed a 36 cytosine-adenine-guanine (CAG) repeat expansion, confirming the diagnosis of SCA2.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>SCA2 should be considered among the possible causes of adult-onset oro-facial dyskinesia, especially when the family history suggests an inherited cerebellar disorder. Additional clinical features, including parkinsonism and motor neuron disease, may represent relevant cues for an early diagnosis and adequate management.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12883-020-01739-8","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T11:03:04Z","timestamp":1587985384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Late-onset oro-facial dyskinesia in Spinocerebellar Ataxia type 2: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Floriana","family":"Giardina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5659-662X","authenticated-orcid":false,"given":"Giuseppe","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cal\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"1739_CR1","first-page":"1","volume":"49","author":"J Jankovic","year":"1988","unstructured":"Jankovic J. Cranial-cervical dyskinesias: an overview. Adv Neurol. 1988;49:1\u201313.","journal-title":"Adv Neurol"},{"key":"1739_CR2","first-page":"842","volume":"60","author":"DH Geschwind","year":"1997","unstructured":"Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 1997;60:842\u201350.","journal-title":"Am J Hum Genet"},{"key":"1739_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.parkreldis.2013.04.012","volume":"19","author":"JL Pedroso","year":"2013","unstructured":"Pedroso JL, Carvalho AA, Escorcio Bezerra ML, Braga-Neto P, Abrah\u00e3o A, Albuquerque MV, et al. Unusual movement disorders in spinocerebellar ataxias. Parkinsonism Relat Disord. 2013;19:834\u20135. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.04.012.","journal-title":"Parkinsonism Relat Disord"},{"key":"1739_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/mds.23584","volume":"26","author":"J van Gaalen","year":"2011","unstructured":"van Gaalen J, Giunti P, van de Warrenburg BP. Movement disorders in spinocerebellar ataxias. Mov Dis. 2011;26:792\u2013800. https:\/\/doi.org\/10.1002\/mds.23584.","journal-title":"Mov Dis"},{"key":"1739_CR5","doi-asserted-by":"publisher","unstructured":"Lanza G, Casabona JA, Bellomo M, Cantone M, Fisicaro F, Bella R, et al. Update on intensive motor training in spinocerebellar ataxia: time to move a step forward? J Int Med Res. 2019;300060519854626. https:\/\/doi.org\/10.1177\/0300060519854626.","DOI":"10.1177\/0300060519854626"},{"key":"1739_CR6","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jamaneurol.2014.2082","volume":"71","author":"AG Neuenschwander","year":"2014","unstructured":"Neuenschwander AG, Thai KK, Figueroa KP, Pulst SM. Amyotrophic lateral sclerosis risk for Spinocerebellar Ataxia type 2 ATXN2 CAG repeat alleles. A Meta-analysis. JAMA Neurol. 2014;71:1529\u201334. https:\/\/doi.org\/10.1001\/jamaneurol.2014.2082.","journal-title":"JAMA Neurol"},{"key":"1739_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/archneur.61.1.35","volume":"61","author":"CS Lu","year":"2004","unstructured":"Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH. The Parkinsonian phenotype of Spinocerebellar Ataxia type 2. Arch Neurol. 2004;61:35\u20138.","journal-title":"Arch Neurol"},{"key":"1739_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ncl.2014.09.008","volume":"33","author":"C Ganos","year":"2015","unstructured":"Ganos C, Martino D. Tics and tourette syndrome. Neurol Clin. 2015;33:115\u201336. https:\/\/doi.org\/10.1016\/j.ncl.2014.09.008.","journal-title":"Neurol Clin"},{"key":"1739_CR9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1136\/jnnp.68.6.738","volume":"68","author":"S Chouinard","year":"2000","unstructured":"Chouinard S, Ford B. Adult onset tic disorders. J Neurol Neurosurg Psychiatry. 2000;68:738\u201343.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01739-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T23:10:29Z","timestamp":1619478629000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01739-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1739"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01739-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave his written informed consent for the publication of his personal and medical information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Giuseppe Lanza is an Associate Editor of BMC Neurology; Floriana Giardina, Francesco Cal\u00ec, and Raffaele Ferri declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}